Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-17-058099

Options or other derivatives

  • Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hunt Andrea · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-10-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +10,000 $4.72 2027-10-25 10,000 10,000 D
Loading xslF345X03/doc4.xml…